SCHEMBL4545217

SCHEMBL4545217

O=C(/C=C/c1ccc(O)c(O)c1)CCc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.67
HSD17B10 Q99714 4/20 0.67
MMP1 P03956 4/20 0.67
MMP2 P08253 4/20 0.67
MMP9 P14780 4/20 0.67
CYP3A4 P08684 3/20 0.67
MAPK1 P28482 3/20 0.67
AKR1B10 O60218 3/20 0.67
TTR P02766 3/20 0.67
AKR1B1 P15121 3/20 0.67
KDM4E B2RXH2 3/20 0.67
APP P05067 3/20 0.67
ALOX15 P16050 2/20 0.67
ALOX12 P18054 2/20 0.67
MEN1 O00255 2/20 0.67
ALDH1A1 P00352 2/20 0.67
LMNA P02545 2/20 0.67
MAPT P10636 2/20 0.67
HPGD P15428 2/20 0.67
PMP22 Q01453 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30449722 1.00 ALOX5 (0.67) ALOX5HSD17B10MMP1MMP2MMP9
SCHEMBL29689081 0.91 ALOX5 (0.67) ALOX5HSD17B10MMP1MMP2MMP9
SCHEMBL14964001 0.91 ALOX5 (0.67) ALOX5HSD17B10MMP1MMP2MMP9
SCHEMBL8392954 0.90 IAPP (0.74) ALOX5HSD17B10MMP1MMP2MMP9
SCHEMBL8392957 0.90 IAPP (0.74) ALOX5HSD17B10MMP1MMP2MMP9
SCHEMBL29489693 0.90 IAPP (0.74) ALOX5HSD17B10MMP1MMP2MMP9
SCHEMBL9683152 0.88 IAPP (0.67) ALOX5HSD17B10MMP1MMP2MMP9
SCHEMBL8848008 0.88 IAPP (0.67) ALOX5HSD17B10MMP1MMP2MMP9
SCHEMBL9695794 0.87 ALOX5 (0.59) ALOX5HSD17B10MMP1MMP2MMP9
SCHEMBL9695492 0.86 ALOX5 (0.58) ALOX5HSD17B10MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3423429-B1 MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY UNIV DE MONCTON (CA) 2023-07-12 EP claimed
US-20230391711-A1 MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY UNIV DE MONCTON (CA) 2023-12-07 US disclosed
EP-4276089-A2 MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY Universite De Moncton (CA) 2023-11-15 EP disclosed
EP-4276089-A2 MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY Universite De Moncton (CA) 2023-11-15 EP disclosed
US-11760715-B2 Modulators of lipoxygenase and cyclooxygenase enzyme activity UNIVERSITÉ DE MONCTON (CA) 2023-09-19 US disclosed
US-11760715-B2 Modulators of lipoxygenase and cyclooxygenase enzyme activity UNIVERSITÉ DE MONCTON (CA) 2023-09-19 US disclosed
US-11760715-B2 Modulators of lipoxygenase and cyclooxygenase enzyme activity UNIVERSITÉ DE MONCTON (CA) 2023-09-19 US disclosed
EP-3423429-B1 MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY UNIV DE MONCTON (CA) 2023-07-12 EP disclosed
EP-3423429-B1 MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY UNIV DE MONCTON (CA) 2023-07-12 EP disclosed
US-20190119194-A1 MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY UNIVERSITE DE MONCTON (CA) 2019-04-25 US disclosed
US-20190119194-A1 MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY UNIVERSITE DE MONCTON (CA) 2019-04-25 US disclosed
US-8716191-B2 Method of preparing an adduct UNIVERSITE DE STRASBOURG (FR) 2014-05-06 US disclosed
US-8716191-B2 Method of preparing an adduct UNIVERSITE DE STRASBOURG (FR) 2014-05-06 US disclosed
US-20120115751-A1 METHOD OF PREPARING AN ADDUCT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2012-05-10 US disclosed
US-20120115751-A1 METHOD OF PREPARING AN ADDUCT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2012-05-10 US disclosed
WO-2010150103-A2 METHOD OF PREPARING AN ADDUCT UNIVERSITE DE STRASBOURG (FR) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760715-B2 Modulators of lipoxygenase and cyclooxygenase enzyme activity ALOX12, ALOX15B, ALOX5 ALOX5 3/4885HSD17B10 216/4885MMP1 1402/4885
US-20190119194-A1 MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY ALOX12, ALOX15B, ALOX5 ALOX5 3/4885HSD17B10 216/4885MMP1 1402/4885
US-20230391711-A1 MODULATORS OF LIPOXYGENASE AND CYCLOOXYGENASE ENZYME ACTIVITY ALOX12, ALOX15B, ALOX5 ALOX5 3/4885HSD17B10 216/4885MMP1 1402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.